Načítá se...
Pixantrone demonstrates significant in vitro activity against multiple myeloma and plasma cell leukemia
Treatment results for multiple myeloma and plasma cell leukemia have considerably improved, but cure remains elusive and establishing new therapeutic approaches constitutes a major unmet clinical need. We analyzed the anti-myeloma properties of the aza-anthracenedione pixantrone which has been succe...
Uloženo v:
| Vydáno v: | Ann Hematol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Berlin Heidelberg
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6848044/ https://ncbi.nlm.nih.gov/pubmed/31628518 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00277-019-03797-6 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|